The infection control market encompasses products, equipment, consumables, and services designed to prevent the spread of infectious diseases in medical and industrial settings. It includes sterilization systems, disinfectants, protective barriers, and professional services used to maintain hygiene compliance and patient safety across clinical channels.
The global infection control market was valued at USD 54.32 billion in 2024, reached USD 57.31 billion in 2025, and is projected to reach USD 77.67 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3%.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1084
The infection control industry market is primarily driven by the rising prevalence of healthcare-associated infections (HAIs), an increasing volume of surgical procedures, and expanding government regulatory mandates focused on patient safety. However, market expansion is heavily restrained by the high upfront capital costs of advanced sterilization equipment and implementation barriers in resource-limited settings, alongside growing concerns regarding the safety of reprocessed instruments. Lucrative opportunities exist in the rising demand from ambulatory surgical centers and outpatient care settings, the growth of single-use disposable products, and the integration of AI-based infection surveillance systems for real-time monitoring. Despite these prospects, the market faces key challenges, including severe hospital workforce shortages, potential supply chain disruptions, and rising antimicrobial resistance that can reduce the efficacy of standard disinfectants.
The target customers for the infection control industry market primarily encompass institutional B2B buyers, heavily dominated by hospitals and clinics, alongside ambulatory surgery centers, medical device manufacturers, pharmaceutical and biologics companies, and diagnostic laboratories. The core needs of these customers revolve around maximizing patient and worker safety, minimizing healthcare-associated infections, and achieving strict regulatory compliance with industry hygiene protocols and environmental standards. They strongly prefer highly reliable, validated infection prevention systems—such as advanced sterilization equipment, automated disinfection technologies, single-use protective barriers, and scalable outsourced contract sterilization services—that seamlessly integrate into daily clinical and production workflows while reducing operational complexity. Their purchasing behavior is defined by high-volume, continuous procurement of recurring consumables like disinfectants and gowns, alongside capital-intensive investments in advanced machinery, heavily influenced by institutional guidelines, safety audits, and a growing emphasis on minimizing total cost of ownership through third-party service models.
Market entry, expansion, and profitability in the infection control industry market are heavily shaped by tightening regulatory frameworks, rapid technological shifts, and pronounced economic pressures. Regulators are intensifying compliance demands, as seen with the U.S. EPA tightening ethylene oxide (EtO) emission limits and the EU Medical Device Regulation raising reprocessing standards, which elevate validation costs for new entrants but drive demand for compliant technologies. Technologically, the market is being disrupted by a paradigm shift away from legacy steam autoclaves toward low-temperature hydrogen peroxide gas plasma sterilizers, alongside the integration of AI-powered environmental surveillance platforms and automated disinfection systems that optimize real-time compliance. Economically, while the rising prevalence of healthcare-associated infections (HAIs) and strict penalty structures—such as CMS withholding reimbursements for elevated infection rates—ensure robust institutional demand, overall profitability faces strong headwinds from the high upfront capital costs of sophisticated sterilization equipment and persistent budget constraints within smaller facilities and resource-limited regional economies.
The infection control industry market is being rapidly reshaped by an accelerating shift toward automated and touchless disinfection technologies, advanced low-temperature sterilization platforms, and integrated infection prevention solutions that bundle equipment, consumables, and services. Healthcare facilities are increasingly adopting AI-driven platforms for real-time compliance analytics and patient risk tracking, alongside a pronounced transition toward outsourcing contract sterilization services to manage tightening regulatory frameworks. These trends are evolving swiftly, as evidenced by steady market acceleration, with the broader infection control sector projected to expand at a compound annual growth rate (CAGR) between 6.2% and 6.6% through the mid-2030s, while highly targeted segments like protective barriers and specialized ambulatory surgery center solutions are advancing at even faster trajectories to support high-volume, rapid room turnarounds.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1084
Technological innovations disrupting the infection control industry market are centered on automation, artificial intelligence (AI), and advanced disinfection modalities. Key advancements gaining significant traction include AI-powered real-time infection surveillance systems, predictive analytics for patient risk-stratification, and electronic hand hygiene monitoring frameworks utilizing computer vision and wearable IoT sensors. Furthermore, the industry is experiencing a material shift toward automated secondary disinfection technologies, notably ultraviolet-c (UV-C) light systems featuring advanced beam steering and autonomous robotic navigation, hydrogen peroxide vapor misting, and innovative molecular diagnostics such as microarrays and multiplex qPCR systems that enable rapid, point-of-care pathogen identification.
In the infection control industry market, short-term trends are characterized by pandemic-driven procurement surges and episodic spikes in public sentiment or social media hype surrounding sudden outbreaks, which trigger immediate, temporary demand for consumables like hand sanitizers, masks, and personal protective equipment. Conversely, long-term structural shifts are firmly anchored in permanent healthcare infrastructure advancements, strict government compliance guidelines, and an aging global population facing a rising burden of chronic illnesses and surgical procedures. These enduring transformations include the widespread clinical adoption of automated sterilization systems, UV-C disinfection technologies, and the integration of AI-driven infection surveillance platforms and digital tracking systems to mitigate the persistent global threat of healthcare-associated infections and antimicrobial resistance.
Source:https://www.marketsandmarkets.com/Market-Reports/infection-control-market-1084.html
